Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | 0.53% | 515.07 | 1.0% | $788.47m | |
| DHR | Danaher Corp. | 2.05% | 237.87 | 0.7% | $564.64m | |
| ABT | Abbott Laboratories | -0.09% | 112.85 | 0.8% | $474.12m | |
| ISRG | Intuitive Surgical, Inc. | -6.84% | 744.08 | 2.3% | $430.78m | |
| MDT | Medtronic Plc | -1.11% | 116.60 | 0.6% | $406.12m | |
| BSX | Boston Scientific Corp. | -1.33% | 37.02 | 1.0% | $353.68m | |
| DXCM | DexCom, Inc. | 0.71% | 370.12 | 7.8% | $340.83m | |
| BDX | Becton, Dickinson & Co. | -1.21% | 258.74 | 1.0% | $296.55m | |
| QDEL | Quidel Corp. | 6.92% | 233.61 | 7.7% | $231.59m | |
| SYK | Stryker Corp. | -1.46% | 240.05 | 1.3% | $224.06m | |
| ALGN | Align Technology, Inc. | -1.79% | 534.08 | 6.4% | $210.31m | |
| A | Agilent Technologies, Inc. | -0.58% | 126.27 | 1.6% | $194.84m | |
| EW | Edwards Lifesciences Corp. | -1.95% | 85.53 | 0.4% | $183.44m | |
| BAX | Baxter International, Inc. | -0.58% | 79.55 | 1.8% | $177.25m | |
| OBLN | Obalon Therapeutics, Inc. | 15.99% | 6.02 | 10.5% | $173.24m |
Company Profile
Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system’s tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.